Skip to main content
Search

# OpenFold3

2 related articles

Subscribe to updates
  1. Nature News

    Drug companies' private protein structures markedly improve AI folding models

    A consortium of pharmaceutical companies called the AI Structural Biology (AISB) Network fine-tuned OpenFold3, previously trained only on PDB data, on 20,167 protein–ligand structures from five companies, and on a held-out test set of 1,056 protein–ligand structures the model reached high accuracy on more than half of them, versus about one-third for the public OpenFold3 and around 40% for the open-source model Boltz-2, while also outperforming models trained only on each company's own data, indicating that pooling data is more valuable than keeping it siloed.

  2. Nature

    Drug Firms' Private Data Supercharge AI Protein Models

    An AI Structural Biology (AISB) network of pharmaceutical companies fine-tuned the open-source model OpenFold3 on 20,167 proprietary protein-ligand structures from five companies; on a held-out test set of 1,056 protein-ligand structures, the model achieved high-accuracy predictions for more than half, compared with one-third for the public version of OpenFold3 and around 40% for the competing open-source model Boltz-2, and it also outperformed models trained only on individual companies' siloed data, indicating that pooling private data markedly improves protein-ligand interaction prediction.

You’re all caught up